Phillip J. Bergen

Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against <i>Pseudomonas aeruginosa</i>

Phillip J. Bergen, Jian Li, Craig R. Rayner et al. · Antimicrobial Agents and Chemotherapy · 2006 · 364 citations · Full text

Life Sciences, Microbiology, Pharmacology +15

Pharmacokinetic/Pharmacodynamic Investigation of Colistin against <i>Pseudomonas aeruginosa</i> Using an <i>In Vitro</i> Model

Phillip J. Bergen, Jürgen B. Bulitta, Alan Forrest et al. · Antimicrobial Agents and Chemotherapy · 2010 · 168 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model

Phillip J. Bergen, Jian Li, Roger L. Nation et al. · Journal of Antimicrobial Chemotherapy · 2008 · 138 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Phillip J. Bergen, Brian T. Tsuji, Jürgen B. Bulitta et al. · Antimicrobial Agents and Chemotherapy · 2011 · 115 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula

Phillip J. Bergen, Alan Forrest, Jürgen B. Bulitta et al. · Antimicrobial Agents and Chemotherapy · 2011 · 114 citations · Full text

Life Sciences, Microbiology, Pharmacology +17